Atticus Wealth Management LLC Buys 252 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Atticus Wealth Management LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 71.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 603 shares of the healthcare conglomerate’s stock after acquiring an additional 252 shares during the quarter. Atticus Wealth Management LLC’s holdings in UnitedHealth Group were worth $299,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Waverly Advisors LLC raised its position in UnitedHealth Group by 8.7% in the 3rd quarter. Waverly Advisors LLC now owns 5,088 shares of the healthcare conglomerate’s stock valued at $2,565,000 after purchasing an additional 407 shares during the last quarter. Hodges Capital Management Inc. acquired a new position in UnitedHealth Group during the 3rd quarter worth about $1,127,000. Kidder Stephen W increased its position in UnitedHealth Group by 10.0% in the 3rd quarter. Kidder Stephen W now owns 13,771 shares of the healthcare conglomerate’s stock valued at $6,943,000 after acquiring an additional 1,251 shares in the last quarter. Gateway Advisory LLC lifted its position in shares of UnitedHealth Group by 2.5% during the third quarter. Gateway Advisory LLC now owns 9,399 shares of the healthcare conglomerate’s stock worth $4,739,000 after purchasing an additional 226 shares in the last quarter. Finally, Provident Investment Management Inc. increased its holdings in shares of UnitedHealth Group by 3.9% in the third quarter. Provident Investment Management Inc. now owns 88,459 shares of the healthcare conglomerate’s stock valued at $44,600,000 after purchasing an additional 3,347 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 4.7 %

Shares of UNH stock traded up $22.82 during trading hours on Friday, hitting $509.26. 22,734,197 shares of the company were exchanged, compared to its average volume of 3,685,941. The company has a market capitalization of $468.72 billion, a PE ratio of 31.13, a PEG ratio of 1.41 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The business has a 50 day moving average of $498.34 and a two-hundred day moving average of $501.96. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the company posted $6.26 earnings per share. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. Analysts anticipate that UnitedHealth Group Incorporated will post 27.57 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a yield of 1.65%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Wall Street Analyst Weigh In

Several research firms have recently commented on UNH. Bank of America reissued a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. TD Cowen dropped their target price on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, June 12th. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.